Discovery of a novel spiropyrimidine scaffold as an orally bioavailable inhibitor of influenza polymerase PB2
Chinese Chemical Letters · 2026-03 · 112678
DOI: 10.1016/j.cclet.2026.112678 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-03. Verfasst von Yuanguang Chen und 13 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shenzhen Science and Technology Innovation Program
- Science and Technology Planning Project of Guangdong Province
- Southern University of Science and Technology
Zitieren
APA
Chen, Y., Rong, B., Zhou, X., Liu, Y., Liang, D., Zheng, P., Lin, S., Lu, K., Wen, Y., Zhao, L., Deng, X., Liu, S., Zhou, Q., & Zhang, X. (2026). Discovery of a novel spiropyrimidine scaffold as an orally bioavailable inhibitor of influenza polymerase PB2. Chinese Chemical Letters, 112678. https://doi.org/10.1016/j.cclet.2026.112678
Vancouver
Chen Y, Rong B, Zhou X, Liu Y, Liang D, Zheng P, et al. Discovery of a novel spiropyrimidine scaffold as an orally bioavailable inhibitor of influenza polymerase PB2. Chinese Chemical Letters. 2026:112678. doi:10.1016/j.cclet.2026.112678
BibTeX
@article{Chen2026,
author = {Chen, Yuanguang and Rong, Binhao and Zhou, Xingyu and Liu, Yongqing and Liang, Dizhen and Zheng, Peisen and Lin, Shudong and Lu, Kunyu and Wen, Yuanmei and Zhao, Liang and Deng, Xinshan and Liu, Shuwen and Zhou, Qifan and Zhang, Xumu},
title = {Discovery of a novel spiropyrimidine scaffold as an orally bioavailable inhibitor of influenza polymerase PB2},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {112678},
doi = {10.1016/j.cclet.2026.112678}
}
EUVIMED